These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

184 related articles for article (PubMed ID: 6981174)

  • 41. Incidence of trimethoprim-sulfamethoxazole-resistant enterobacteriaceae among transplant recipients.
    Wells CL; Podzorski RP; Peterson PK; Ramsay NK; Simmons RL; Rhame FS
    J Infect Dis; 1984 Nov; 150(5):699-706. PubMed ID: 6387000
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Efficacy of initial caspofungin plus trimethoprim/sulfamethoxazole for severe PCP in patients without human immunodeficiency virus infection.
    Qi H; Dong D; Liu N; Xu Y; Qi M; Gu Q
    BMC Infect Dis; 2023 Jun; 23(1):409. PubMed ID: 37328748
    [TBL] [Abstract][Full Text] [Related]  

  • 43. The effect of trimethoprim and sulfamethoxazole on Toxoplasma gondii in vitro and in vivo.
    Grossman PL; Remington JS
    Am J Trop Med Hyg; 1979 May; 28(3):445-55. PubMed ID: 453442
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Comparative efficacy and safety of nalidixic acid versus trimethoprim/sulfamethoxazole in treatment of acute urinary tract infections in college-age women.
    Iravani A; Richard GA; Baer H; Fennell R
    Antimicrob Agents Chemother; 1981 Apr; 19(4):598-604. PubMed ID: 6972732
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Prevention of infection in acute leukemia: a prospective randomized study on the efficacy of two different drug regimens for antimicrobial prophylaxis.
    Kurrle E; Dekker AW; Gaus W; Haralambie E; Krieger D; Rozenberg-Arska M; de Vries-Hospers HG; van der Waaij D; Wendt F
    Infection; 1986; 14(5):226-32. PubMed ID: 3491791
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Pharmacokinetics of sulfamethoxazole--trimethoprim combination during chronic peritoneal dialysis: effect of peritonitis.
    Singlas E; Colin JN; Rottembourg J; Meessen JP; de Martin A; Legrain M; Simon P
    Eur J Clin Pharmacol; 1982; 21(5):409-15. PubMed ID: 7075646
    [TBL] [Abstract][Full Text] [Related]  

  • 47. [Thiamphenicol versus trimethoprim-sulfamethoxazole in bacterial exacerbations of chronic unspecific respiratory tract diseases. A controlled study].
    Medici TC; Hermann R; Lualdi P; Frigerio G
    Schweiz Med Wochenschr; 1980 Jul; 110(30):1128-37. PubMed ID: 6999618
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Similar hematologic changes in children receiving trimethoprim-sulfamethoxazole or amoxicillin for otitis media.
    Feldman S; Doolittle M; Lott L; Roberson P; Hughes WT
    J Pediatr; 1985 Jun; 106(6):995-1000. PubMed ID: 3889261
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Trimethoprim-sulfamethoxazole.
    Cockerill FR; Edson RS
    Mayo Clin Proc; 1987 Oct; 62(10):921-9. PubMed ID: 3498863
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Empiric antimicrobial therapy in febrile granulocytopenic patients. Randomized prospective comparison of amikacin plus piperacillin with or without parenteral trimethoprim/sulphamethoxazole.
    Menichetti F; Del Favero A; Guerciolini R; Tonato M; Aversa F; Roila F; Frongillo RF; Martelli MF; Davis S; Pauluzzi S
    Infection; 1986; 14(6):261-7. PubMed ID: 3546144
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Comparison of ceftriaxone and trimethoprim-sulfamethoxazole for acute otitis media. Greater Boston Otitis Media Study Group.
    Barnett ED; Teele DW; Klein JO; Cabral HJ; Kharasch SJ
    Pediatrics; 1997 Jan; 99(1):23-8. PubMed ID: 8989332
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Trimethoprim-sulfamethoxazole plus amikacin as first-line therapy and imipenem/cilastatin as second empirical therapy in febrile neutropenic patients with hematological disorders.
    Engervall PA; Stiernstedt GT; Günther GC; Björkholm MJ
    J Chemother; 1992 Apr; 4(2):99-106. PubMed ID: 1629753
    [TBL] [Abstract][Full Text] [Related]  

  • 53. The influence of PCP prophylaxis on bacteriuria incidence and resistance development to trimethoprim/sulfamethoxazole in HIV-infected patients.
    van Dooyeweert DA; Schneider MM; Borleffs JC; Hoepelman AI
    Neth J Med; 1996 Dec; 49(6):225-7. PubMed ID: 8990860
    [TBL] [Abstract][Full Text] [Related]  

  • 54. TMP-SMZ in the treatment of brucellar meningitis.
    Roldan A; Molina JA; Fernandez A; Zancada F; Gutierrez A
    Rev Infect Dis; 1988; 10(6):1233-4. PubMed ID: 3264615
    [No Abstract]   [Full Text] [Related]  

  • 55. Comparison of pentamidine isethionate and trimethoprim-sulfamethoxazole in the treatment of Pneumocystis carinii pneumonia.
    Hughes WT; Feldman S; Chaudhary SC; Ossi MJ; Cox F; Sanyal SK
    J Pediatr; 1978 Feb; 92(2):285-91. PubMed ID: 304478
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Use of trimethoprim alone or in combination with drugs other than sulfonamides.
    Brumfitt W; Hamilton-Miller JM
    Rev Infect Dis; 1982; 4(2):402-10. PubMed ID: 7051238
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Bladder instillations with trimethoprim-sulfamethoxazole in the treatment of urinary infection.
    Hachen HJ
    Chemotherapy; 1978; 24(1):55-60. PubMed ID: 338266
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Antimicrobial therapy for travelers' diarrhea.
    DuPont HL; Ericsson CD; Reves RR; Galindo E
    Rev Infect Dis; 1986; 8 Suppl 2():S217-22. PubMed ID: 3523718
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Urinary prophylaxis with trimethoprim and trimethoprim-sulfamethoxazole: efficacy, influence on the natural history of recurrent bacteriuria, and cost control.
    Stamm WE; Counts GW; McKevitt M; Turck M; Holmes KK
    Rev Infect Dis; 1982; 4(2):450-5. PubMed ID: 6981163
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Selective gut decontamination with nalidixic acid or trimethoprim-sulfamethoxazole for infection prophylaxis in neutropenic cancer patients: relationship of efficacy to antimicrobial spectrum and timing of administration.
    Bow EJ; Rayner E; Scott BA; Louie TJ
    Antimicrob Agents Chemother; 1987 Apr; 31(4):551-7. PubMed ID: 3300532
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.